Fig. 3From: SPON1 is an independent prognostic biomarker for ovarian cancerHigh SPON1 expression is associated with poor outcomes in ovarian cancer patients. (A) The disease-specific and (B) recurrence-free survival for the SPON1-low and SPON1-high expression groups in ovarian cancer subjects are indicatedBack to article page